An update on joint-specific outcome measures in total hip replacement

Pulik, Łukasz; Romaniuk, Krzysztof; Jaśkiewicz, Kaja; Wojtyński, Paweł; Łęgosz, Paweł; Małdyk, Paweł

doi:10.5114/reum.2020.95366

Cited by 11 publications

(9 citation statements)

References 50 publications

(75 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Psychiatric disorders are associated with less satisfactory functional outcomes and less improvement in life quality, pain and satisfaction after surgery, prolonged hospitalization, complications, and increased mortality [ 84 , 85 ]. Undeniably, the coexisting diseases can impact THA results, both traditional outcomes like mortality, risk of adverse events, or revision, and patient-oriented outcomes such as quality of life, physical function, and satisfaction [ 4 ]. Identifying patients at high risk of complications can lead to adequate qualification for the procedure and initiation of more rigorous prophylaxis.…”

Section: Discussionmentioning

confidence: 99%

“…According to research, 83.7% of patients undergoing hip surgery suffer from comorbidities [ 3 ]. Researchers indicate that concomitant diseases can affect the outcome of THA, including postoperative complications, risk of reoperation, cost of patient's treatment, future mobility of the patient, and outcomes represented by joint-specific measures including: Western and McMaster Universities Osteoarthritis Index (WOMAC), the Hip Disability and Osteoarthritis Outcome Score (HOOS), the Harris Hip Score (HHP), the Oxford Hip Score (OHS) and the Mayo Hip Score (MHS) [ 4 ]. Hence, the in-depth evaluation of comorbidities is vital for predicting THA outcomes [ 5 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Update on Instruments Used for Evaluation of Comorbidities in Total Hip Arthroplasty

Pulik

Podgajny

Kaczyński

et al. 2021

JOIO

Self Cite

View full text Add to dashboard Cite

Introduction It is a well-established fact that concomitant diseases can affect the outcome of total hip arthroplasty (THA). Therefore, careful preoperative assessment of a patient's comorbidity burden is a necessity, and it should be a part of routine screening as THA is associated with a significant number of complications. To measure the multimorbidity, dedicated clinical tools are used. Methods The article is a systematic review of instruments used to evaluate comorbidities in THA studies. To create a list of available instruments for assessing patient's comorbidities, the search of medical databases (PubMed, Web of Science, Embase) for indices with proven impact on revision risk, adverse events, mortality, or patient's physical functioning was performed by two independent researchers. Results The initial search led to identifying 564 articles from which 26 were included in this review. The measurement tools used were: The Charlson Comorbidity Index (18/26), Society of Anesthesiology classification (10/26), Elixhauser Comorbidity Method (6/26), and modified Frailty Index (5/26). The following outcomes were measured: quality of life and physical function (8/26), complications (10/26), mortality (8/26), length of stay (6/26), readmission (5/26), reoperation (2/26), satisfaction (2/26), blood transfusion (2/26), surgery delay or cancelation (1/26), cost of care (1/26), risk of falls (1/26), and use of painkillers (1/26). Further research resulted in a comprehensive list of eleven indices suitable for use in THA outcomes studies. Conclusion The comorbidity assessment tools used in THA studies present a high heterogeneity level, and there is no particular system that has been uniformly adopted. This review can serve as a help and an essential guide for researchers in the field.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

The Update on Instruments Used for Evaluation of Comorbidities in Total Hip Arthroplasty

Pulik

Podgajny

Kaczyński

et al. 2021

JOIO

Self Cite

View full text Add to dashboard Cite

show abstract

“…A higher score indicates higher level of pain, stiffness or disability. A total score is suggested by summation of the scores from three domains [ 28 , 29 ], and has been widely used in clinical trials of hip and knee OA [ 30 ]. Despite its use, there appears to be little psychometric evidence to-date to support a total score.…”

Section: Methodsmentioning

confidence: 99%

Validation and interval scale transformation of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in patients undergoing knee arthroplasty, using the Rasch model

Leung

Thumboo

Yeo

et al. 2022

Osteoarthritis and Cartilage Open

View full text Add to dashboard Cite

“…The WOMAC score was calculated from the Hip Osteoarthritis Outcome Score (HOOS) questionnaire according to the authors’ recommendation [ 16 ]. During the follow-up visits, an orthopedic examination was performed.…”

Section: Variables and Data Sourcesmentioning

confidence: 99%

Modified frailty index as a predictor of the long-term functional result in patients undergoing primary total hip arthroplasty

Pulik¹,

Jaśkiewicz²,

Sarzyńska³

et al. 2020

Reumatologia

Self Cite

View full text Add to dashboard Cite

Objectives: Total hip arthroplasty (THA) is a well-approved method for the treatment of end-stage osteoarthritis (OA). Due to rising life expectancy, elderly patients burdened with multimorbidity are subjected to THA. Some of these patients present significant depletion of physiological reserves, which is described as the frailty syndrome. This study aims to assess the influence of frailty on the THA outcomes in OA patients. Material and methods: A single-center observational study was conducted to investigate the effect of frailty measured by the modified frailty index-5 (mFI-5) and modified frailty index-11 (mFI-11) on the long-term post-THA outcomes. The analysis included 597 initially screened patients subjected to unilateral, primary THA due to hip OA. The outcomes were assessed during a follow-up visit 3 years after THA. The primary outcome measures were patient-reported (the Western Ontario and McMaster Universities Osteoarthritis Index-WOMAC) and physician-reported scales (the Harris Hip Score-HHS). The secondary outcome measures were the length of hospital stay (LOS), pain complaints, complications, and satisfaction. A correlation analysis was performed (Spearman's R). Results: Three hundred sixty-five patients met the eligibility criteria, including 57.26% women (n = 209) and 42.74% men (n = 156). The mean age was 65.11 ±12.12 years. Patients with high values of mFI-5 (r = 0.19; p < 0.05) and mFI-11 (r = 0.22; p < 0.01) achieved less satisfactory functional outcomes after THA (WOMAC). After age adjustment, mFI-11 (r = 0.17; p < 0.05) was a better predictor of functional outcome (WOMAC) than mFI-5 was (r = 0.15; p = 0.07). The mFI-5 (r = 0.25; p < 0.001) and mFI-11 (r = 0.29; p < 0.001) correlated with longer LOS. Conclusions: The modified frailty index-5 (mFI-5) and modified frailty index-11 (mFI-11) are useful tools to identify patients subjected to THA at a high risk of poor functioning after the procedure. They can be used in preoperative counseling before obtaining informed consent to support surgical decision-making. To our knowledge, this is the first study investigating the impact of the mFI on long-term postoperative functional results in OA treated with THA.

show abstract

An update on joint-specific outcome measures in total hip replacement

Cited by 11 publications

References 50 publications

The Update on Instruments Used for Evaluation of Comorbidities in Total Hip Arthroplasty

The Update on Instruments Used for Evaluation of Comorbidities in Total Hip Arthroplasty

Validation and interval scale transformation of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in patients undergoing knee arthroplasty, using the Rasch model

Modified frailty index as a predictor of the long-term functional result in patients undergoing primary total hip arthroplasty

Contact Info

Product

Resources

About